Brazil consortium manufacturers

Bionovis is a leading Brazilian biotechnology company established as a joint venture between four of the country's largest pharmaceutical manufacturers: Aché, EMS, Hypera Pharma, and União Química. Founded in 2012, the company operates as a strategic consortium dedicated to the development, production, and commercialization of high-complexity biological medicines, with a primary focus on biosimilars. Bionovis utilizes a collaborative business model to leverage the manufacturing and distribution strengths of its parent companies while maintaining its own advanced R&D and production facilities in Valinhos, São Paulo. The company's portfolio includes several approved monoclonal antibodies and recombinant proteins for the treatment of cancer and autoimmune diseases, supported by strategic partnerships with global leaders such as Janssen and Merck. Bionovis plays a pivotal role in the Brazilian government's Productive Development Partnership (PDP) program, aimed at fostering domestic innovation and expanding patient access to advanced therapies.